244 related articles for article (PubMed ID: 2435803)
1. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
4. A novel early antigen associated with Epstein-Barr virus productive cycle.
Freemer CS; Bertoni G; Takagi S; Sairenji T
Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
[TBL] [Abstract][Full Text] [Related]
5. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
7. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
8. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
10. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
11. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
[TBL] [Abstract][Full Text] [Related]
12. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Szekely L; Pokrovskaja K; Klein G
Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
18. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
Xia Q; Meng G; Ai Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
[TBL] [Abstract][Full Text] [Related]
19. Detection of an idiotope on a human monoclonal autoantibody by monoclonal anti-idiotypic antibody and its relationship to Epstein-Barr virus-induced autoimmunity.
Garzelli C; Incaprera M; Bazzichi A; Falcone G
Autoimmunity; 1992; 11(3):171-7. PubMed ID: 1315162
[TBL] [Abstract][Full Text] [Related]
20. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA).
Garzelli C; Pacciardi A; Carmignani M; Conaldi G; Basolo F; Falcone G
Immunol Lett; 1989 Sep; 22(3):211-6. PubMed ID: 2478456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]